Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis.
about
Current and emerging treatment options in the management of lupusCoronary artery disease in patients with systemic lupus erythematosusDeterminants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus.Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort.Drugs to Treat Systemic Lupus Erythematosus: Relationship between Current Use and Cardiovascular Risk Factors.Accelerated atheroma in lupus--background.Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort.Variability over time and correlates of cholesterol and blood pressure in systemic lupus erythematosus: a longitudinal cohort study.Antimalarials--the 'real' advance in lupus.What will treatment of autoimmune diseases entail in 2010?A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role.Systemic lupus erythematosus: review of synthetic drugs.Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit.Prevalence of LDL atherogenic phenotype in patients with systemic lupus erythematosus.Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study.Myocardial revascularization in two patients associated with antiphospholipid syndrome: different pathogenic patterns and angiographic resultsEffect of hydroxychloroquine on insulin sensitivity and lipid parameters in rheumatoid arthritis patients without diabetes mellitus: a randomized, blinded crossover trial.Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study.African-American and Hispanic ethnicities, renal involvement and obesity predispose to hypertension in systemic lupus erythematosus: results from LUMINA, a multiethnic cohort (LUMINAXLV)Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus.Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus.'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.Lupus in Baltimore: evidence-based 'clinical pearls' from the Hopkins Lupus Cohort.Contemporary treatment of systemic lupus erythematosus: an update for clinicians.The management of pediatric systemic lupus erythematosus.Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosusEarly atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factorsCardiovascular risk in pediatric-onset rheumatological diseases.Management of dyslipidemia in children and adolescents with systemic lupus erythematosus.Accelerated atherosclerosis in rheumatoid arthritis.Hypertension in rheumatoid arthritis.The effect of hydroxychloroquine on glucose control and insulin resistance in the prediabetes condition.Drugs Used in the Treatment of Rheumatoid Arthritis: Relationship between Current Use and Cardiovascular Risk Factors.Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohortAtherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events.The role of antimalarial agents in the treatment of SLE and lupus nephritis.Glucocorticoid use and abuse in SLE.Utilizing registries in systemic lupus erythematosus clinical research.New insights into mechanisms of therapeutic effects of antimalarial agents in SLE.
P2860
Q26741266-DF62D34A-5CD9-4103-B031-0EAE3065B106Q28200286-18A728F5-A945-4111-B57A-7B05B5D3C972Q33422958-24B93F02-1CB5-4FBA-AB41-336D158C7492Q33448450-62935C9E-7E1D-48D3-ACD1-0310B705495FQ33633643-77F23085-2E8D-496B-8F80-2678D9116533Q33915419-A8599D5A-8271-49A7-88F6-93C7CB1AEB45Q33915430-D4A0413E-F6E5-4E23-974E-FF5896187F74Q34027673-3DD2A7CB-4359-43DA-BDA4-0DA7393CD858Q34297582-70E6DB93-6BBD-4325-8CEB-3D41482F2103Q34309722-71BF511E-F24E-457A-9B79-E87A64BA0197Q34389286-BC01E1BB-64E0-4C27-AD0C-3938BC89528CQ34498515-C8369E27-42DA-42B3-9150-DA483D5FBD76Q34601733-6A04ADC5-925B-4DBC-9D37-E776367386EEQ34604474-64161179-3B65-44AA-BB20-96D3B09E74EFQ34627711-BBD261BB-D3C4-409E-8E57-1208095C8B57Q35617716-18856C7D-5AD7-47E2-8EE0-2AC12DC12AA6Q35724006-8AB651DC-B4BA-4F9D-B25A-AC5D4D6D23D3Q35742831-4C83F5A8-4013-4D62-BAA8-5863F3AF861EQ35840758-BD5F19F8-38A3-4302-A4D5-04989A68488EQ35953274-0FC9368A-AC84-4CDE-BB73-AECCCE733879Q35954549-9D513DDB-EBF0-46FD-8B84-796531EFCDB1Q36126483-6570C414-D96D-4958-A401-D74D3180B002Q36290168-9ABCE1CD-D9F1-442C-BF87-802D32A0B6BAQ36373318-6849E526-7EC7-4186-9274-1BCF94EE640FQ36443689-DD3B61F9-C69D-4633-B0C5-13842E33C6A0Q36577380-26848427-01A6-4AB1-8CB1-21DF1FE33550Q36606667-36AB44CB-058E-4386-932D-E093C5EC3B03Q36757042-6903C1BA-9D38-40B4-9EEB-A62D233218D3Q36903089-CDE9983D-C663-4C5D-A4BF-BCF36CB8481DQ36915663-D1E2A215-014B-4AB1-A408-3B13D88EB499Q36951047-6EA1E98B-59A3-4953-8205-25935316594BQ37158219-7E85DDCA-FD6E-4241-8E70-B525FF450C94Q37261219-F2D4F57E-D0EE-4448-A98D-54B47371917FQ37292191-33FDDD0B-2F4B-4641-A971-C57246975880Q37406201-D6B68466-784A-4C74-BE14-5D37AEE36241Q37690605-E0FF9146-BFA9-404A-A2C2-A35007FF00E2Q37947108-4F415634-D0D6-4293-A145-54DBBBFB229AQ37978291-0CD2AD90-BCE8-4874-96BD-09A2B3B81F56Q38011226-1FF7E4F1-D297-4C5B-B521-EE58305B215CQ38026787-8E9C08EA-01F4-4390-A91D-6D9ADF5D3B6E
P2860
Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Effect of prednisone and hydro ...... a longitudinal data analysis.
@en
type
label
Effect of prednisone and hydro ...... a longitudinal data analysis.
@en
prefLabel
Effect of prednisone and hydro ...... a longitudinal data analysis.
@en
P2093
P1476
Effect of prednisone and hydro ...... a longitudinal data analysis.
@en
P2093
P304
P356
10.1016/0002-9343(94)90151-1
P407
P577
1994-03-01T00:00:00Z